Carmat SA
PAR:ALCAR
Carmat SA
EPS (Diluted)
Carmat SA
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Carmat SA
PAR:ALCAR
|
EPS (Diluted)
-€1
|
CAGR 3-Years
18%
|
CAGR 5-Years
21%
|
CAGR 10-Years
11%
|
|
|
Edap Tms SA
NASDAQ:EDAP
|
EPS (Diluted)
€0
|
CAGR 3-Years
-112%
|
CAGR 5-Years
-124%
|
CAGR 10-Years
-10%
|
|
|
Biomerieux SA
PAR:BIM
|
EPS (Diluted)
€3
|
CAGR 3-Years
-10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
|
|
Biosynex SA
PAR:ALBIO
|
EPS (Diluted)
-€3
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-9%
|
|
|
Visiomed Group SA
PAR:ALVMG
|
EPS (Diluted)
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amplitude Surgical SA
PAR:AMPLI
|
EPS (Diluted)
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Carmat SA
Glance View
Carmat SA engages in the developing of implantable orthotropic and biocompatible artificial heart. The company is headquartered in Velizy-Villacoublay, Ile-De-France and currently employs 160 full-time employees. The company went IPO on 2010-07-07. The firm is developing an orthotopic and biocompatible artificial heart which works like a natural heart and which is hydraulically activated. The firm formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels and Blood Institute, Laboratoire de Recherche Biochirurgicale and others. As of December 31, 2011, a company MATRA DEFENSE held a 30.57% stake in the Company’s shareholdings.
See Also
What is Carmat SA's EPS (Diluted)?
EPS (Diluted)
-1.5
EUR
Based on the financial report for Jun 30, 2024, Carmat SA's EPS (Diluted) amounts to -1.5 EUR.
What is Carmat SA's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
11%
Over the last year, the EPS (Diluted) growth was 36%. The average annual EPS (Diluted) growth rates for Carmat SA have been 18% over the past three years , 21% over the past five years , and 11% over the past ten years .
You don't have any saved screeners yet